Breast Tumor Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Phase 2 trial investigators hope denifanstat can be a key component in restoring sensitivity to HER2- positive metastatic breast cancer treatments.

United statesMayo clinic in rochesterKarthikv giridharDivision of medical oncologyDepartment of oncologyBreast tumor groupMedical oncologyMayo clinicPhase efficacy seenAdvanced solid tumorsHer2 positive metastatic breast cancerMayo clinic